| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |